Work

Evaluation of orphan maintained biological medicinal products in the European Union between 2018 to 2023: a regulatory perspective

Year: 2024

Type: article

Source: Expert Opinion on Biological Therapy

DOI: 10.1080/14712598.2024.2422360

Authors: Paolo Caferra, Thomas Fraisse, Maria Letizia Trincavelli, Laura Marchetti, Anna Maria Piras

Institutions: University of Pisa, Sanofi (Netherlands), Université de Montpellier

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403793532

FWCI: 0.362

Cites: 63

Cited by: 1

Related to: 10